Successful clinical response to irinotecan in desmoplastic round blue cell tumor.
Rosoff
P M
PM
Division of Hematology-Oncology, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA. rosof001@mc.duke.edu
Bayliff
S
S
D000008:Abdominal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000293:Adolescent; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000473:pathology; D003893:Desmin / Q000032:analysis; D005260:Female; D006801:Humans; D000077146:Irinotecan; D008297:Male; D011379:Prognosis; D016896:Treatment Outcome
D000972:Antineoplastic Agents, Phytogenic; D003893:Desmin; D000077146:Irinotecan; D002166:Camptothecin